Endocrinology, Vol 125, 1556-1564, Copyright © 1989 by Endocrine Society

ARTICLES

A dominant phenocopy of hypopituitarism in transgenic mice resulting from central nervous system synthesis of human growth hormone

PG Hollingshead, L Martin, SL Pitts and TA Stewart
Department of Developmental Biology, Genentech, Inc., South San Francisco, California 94080.

We have produced a line of transgenic mice in which expression of human GH has been detected only in the cerebral cortex. Both male and female transgenic mice are growth inhibited with respect to their nontransgenic littermates. Mouse GH mRNA and insulin-like growth factor- I mRNA levels in the pituitary and liver, respectively, are reduced, and circulating insulin-like growth factor-I levels are lower in these mice. Within the hypothalamus somatostatin mRNA levels are increased and GH-releasing factor mRNA levels are reduced compared to those in nontransgenic littermates. We suggest that the growth retardation in these mice is a consequence of the ectopic human GH disturbing the normal controls that regulate mouse GH synthesis and release from the pituitary. These mice provide a resource for analysis of the regulation of GH production and demonstrate that a dominant phenocopy can be made by producing transgenic mice that have local production of an extra- cellular hormone.

This article has been cited by other articles:

				P. R. Le Tissier, D. F. Carmignac, S. Lilley, A. K. Sesay, C. J. Phelps, P. Houston, K. Mathers, C. Magoulas, D. Ogden, and I. C. A. F. Robinson Hypothalamic Growth Hormone-Releasing Hormone (GHRH) Deficiency: Targeted Ablation of GHRH Neurons in Mice Using a Viral Ion Channel Transgene Mol. Endocrinol., May 1, 2005; 19(5): 1251 - 1262. [Abstract] [Full Text] [PDF]

				M. Bohlooly-Y, B. Olsson, C. E.G. Bruder, D. Linden, K. Sjogren, M. Bjursell, E. Egecioglu, L. Svensson, P. Brodin, J. C. Waterton, et al. Growth Hormone Overexpression in the Central Nervous System Results in Hyperphagia-Induced Obesity Associated With Insulin Resistance and Dyslipidemia Diabetes, January 1, 2005; 54(1): 51 - 62. [Abstract] [Full Text] [PDF]

				F. Obal Jr, J. Fang, P. Taishi, B. Kacsoh, J. Gardi, and J. M. Krueger Deficiency of Growth Hormone-Releasing Hormone Signaling Is Associated with Sleep Alterations in the Dwarf Rat J. Neurosci., April 15, 2001; 21(8): 2912 - 2918. [Abstract] [Full Text] [PDF]

				E. Pellegrini, D. F. Carmignac, M. T. Bluet-Pajot, F. Mounier, P. Bennett, J. Epelbaum, and I. C. A. F. Robinson Intrahypothalamic Growth Hormone Feedback: From Dwarfism to Acromegaly in the Rat Endocrinology, November 1, 1997; 138(11): 4543 - 4551. [Abstract] [Full Text] [PDF]

				T. Wells, D. M. Flavell, S. E. Wells, D. F. Carmignac, and I. C. A. F. Robinson Effects of Growth Hormone Secretagogues in the Transgenic Growth-Retarded (Tgr) Rat Endocrinology, February 1, 1997; 138(2): 580 - 587. [Abstract] [Full Text] [PDF]